US EditionHighlights of U.S.-India Interim Trade Framework
The US and India agreed on an interim trade framework to lower tariffs and address barriers, with India committing to purchase $500 billion in US goods over five years.
- On Saturday, India and the United States announced an Interim Trade Agreement framework to lower tariffs, address non‑tariff barriers and strengthen ties, the joint statement said it marks a historic milestone.
- The new framework reassures commitment to the broader US-India Bilateral Trade Agreement negotiations launched last year and aims to support more resilient supply chains and resolve non-tariff barriers affecting food and agricultural products.
- The US will apply a reciprocal 18% tariff on certain goods, while India will eliminate or reduce tariffs on US industrial products and food items such as DDGs, tree nuts, and fruit.
- India intends to purchase USD 500 billion of US energy products and technology over the next five years, while outcomes for generic pharmaceuticals depend on a US investigation and tariff removals.
- They will establish rules of origin to lock in benefits for both parties, while India addresses barriers to US medical devices and ICT licensing, deciding within six months on standards.
18 Articles
18 Articles
‘Prosperous Path Forward’: White House Releases Mega Fact Sheet On India-US Trade Deal; $500 Billion Purchase Goal Detailed
The joint announcement also highlights India’s undertaking to tackle non-tariff barriers that hinder trade between the two countries in identified priority sectors.
India-US trade deal to make sure only Indian and American products get the benefits, White House says
The US and India have agreed on a framework for an interim reciprocal trade deal, aiming for balanced market access and tariff reductions. This arrangement seeks to benefit both nations by expanding trade, aligning economic and national security priorities, and deepening bilateral cooperation.
US Tariff Cut to Benefit India's AYUSH, Nutraceutical Sectors Under Interim Trade Deal: Pharmanza Herbal Founder
Get latest articles and stories on Business at LatestLY. India's AYUSH and nutraceutical sectors are expected to see a significant boost following the reduction in US tariffs under the India-US Interim Trade Deal, Founder & Director of Pharmanza Herbal Pvt Ltd, Lal Hingorani, said in an exclusive conversation with ANI. Business News | US Tariff Cut to Benefit India's AYUSH, Nutraceutical Sectors Under Interim Trade Deal: Pharmanza Herbal Founder.
digitimes.com
technewstube.comUS and India agree framework for interim trade deal to advance bilateral pact talks
The US and India have agreed on a framework for an interim trade agreement aimed at expanding market access and strengthening supply chains, marking a step toward a broader bilateral trade agreement launched earlier this year by President Donald Trump and Prime Minister Narendra Modi.
Coverage Details
Bias Distribution
- 38% of the sources are Center, 37% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
